Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6867251 | 0.89 | MEN1 (0.35) | MEN1ALDH1A1KMT2ATDP1 | |
| SCHEMBL1806236 | 0.89 | MEN1 (0.35) | MEN1ALDH1A1KMT2ATDP1 | |
| SCHEMBL1811988 | 0.88 | MEN1 (0.38) | MEN1ALDH1A1KMT2ATDP1 | |
| SCHEMBL1810542 | 0.86 | MEN1 (0.36) | MEN1ALDH1A1KMT2ATDP1 | |
| SCHEMBL6060779 | 0.86 | MEN1 (0.36) | MEN1ALDH1A1KMT2ATDP1 | |
| SCHEMBL23360936 | 0.84 | MEN1 (0.36) | MEN1ALDH1A1KMT2ATDP1 | |
| SCHEMBL809345 | 0.82 | VCP (0.33) | MEN1ALDH1A1KMT2ATDP1 | |
| SCHEMBL1814370 | 0.81 | MEN1 (0.33) | MEN1ALDH1A1KMT2ATDP1 | |
| SCHEMBL419449 | 0.78 | VCP (0.38) | MEN1ALDH1A1KMT2ATDP1 | |
| SCHEMBL1817102 | 0.76 | MEN1 (0.33) | MEN1ALDH1A1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1915331-B1 | PRODUCTION PROCESS OF NUCLEUS-HALOGENATED METHYLBENZYL ALCOHOL | SHOWA DENKO KK (JP) | 2013-07-10 | — | — | EP | disclosed |
| US-7939695-B2 | Production process of nucleus-halogenated methylbenzyl alcohol | SHOWA DENKO K.K. (JP) | 2011-05-10 | — | — | US | disclosed |
| CN-101193843-B | Production process of nucleus-halogenated methylbenzyl alcohol | SHOWA DENKO KK | 2011-05-04 | — | — | CN | disclosed |
| US-20100145106-A1 | PRODUCTION PROCESS OF NUCLEUS-HALOGENATED METHYLBENZYL ALCOHOL | SHOWA DENKO K.K. (JP) | 2010-06-10 | — | — | US | disclosed |
| CN-101193843-A | Production process of nucleus-halogenated methylbenzyl alcohol | SHOWA DENKO KK (JP) | 2008-06-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100145106-A1 | PRODUCTION PROCESS OF NUCLEUS-HALOGENATED METHYLBENZYL ALCOHOL | NPM1, MED1, KPNA2 | MEN1 110/4885ALDH1A1 1151/4885KMT2A 365/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.